Predictors of uncircumcised primary school girls' intention to genital cutting in South Ethiopia: Application of theory of planned behavior.

BACKGROUND: Female genital cutting (FGC) is still among the most common harmful traditional practices, especially in Africa and Asia. Despite the existence of rich evidence on the prevalence of FGC, information about the primary target audiences' (girls') intention toward FGC is limited. Therefore, this study aimed to identify the predictors of primary school girls' behavioral intention toward female genital cutting. METHODS: An institution-based cross-sectional study was conducted from May 08 to 28, 2019 in Dunna district, South Ethiopia. A two-stage sampling technique was used to select 354 uncircumcised female students. A self-administered pre-tested structured questionnaire was used for data collection. Data were entered into Epi data manager version 4.0.2 and exported to STATA version 16.0. Descriptive analyses such as frequency, percentage, mean and standard deviation were performed as necessary. Univariable and multivariable linear regression analyses were conducted to identify predictors of primary school girls' intention to experience FGC. RESULTS: The mean age of the respondents was 13.09±1.69 years with an age range of 10 to 18 years. Of the 354 respondents, 156 (44.1%) intended to experience FGC. The model accounted for 76.58% of the variance in primary school girls' intention to experience FGC. Among socio-demographic characteristics, mothers' educational level of ≤8 grade (ß = 1.95, p<0.001) and the age of the respondents (ß = -0.23, p = 0.036) predicted primary school girls' intention toward FGC. Among the constructs of the theory of planned behavior (TPB), direct perceived behavioral control (ß = 0.47, p = 0.015), indirect perceived behavioral controls (ß = 0.05, p = 0.002), and direct subjective norms (ß = 0.18, p = 0.039) predicted primary school girls' intention to experience FGC. CONCLUSIONS: In this study, we found that primary school girls' intention toward FGC was high. The educational level of mothers and the age of the respondents had a great influence on primary school girls' intention to experience FGC. Perceived lack of power and social pressure also predicted primary school girls' intention to engage in genital cutting. The findings suggest that FGC is mainly performed by the decision of the parents irrespective of the girls' preferences. Therefore, behavioral change communication interventions such as media campaigns, peer education and community dialogue guided by the TPB for empowering girls to confront FGC and reducing the influence of referents need to be focused.

A study in a rat initiation-promotion bladder tumour model demonstrated no promoter/progressor potential of dapagliflozin.

Dapagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, is indicated to improve glycaemic control in adults of type 2 diabetes. In nonclinical studies, dapagliflozin was neither genotoxic nor carcinogenic. However, in some clinical studies, an increased incidence of bladder cancer was observed in the dapagliflozin group vs. the placebo. Therefore, this study was undertaken to determine if dapagliflozin can act as a promoter in a 2-stage bladder cancer model in rats induced with N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN). Rats given BBN (100 or 400 mg/kg, po) twice weekly for 6 weeks in Phase 1 were assigned in Phase 2 to receive daily dose of vehicle, dapagliflozin (0.5 mg/kg, po) or uracil (positive control, 3% in diet) from weeks 8-34. All bladders were evaluated by histopathology. Verifying the validity of the model, uracil increased the incidence of bladder cancer, while dapagliflozin had no effect on the incidence or invasiveness of transitional cell carcinoma. The exposure of dapagliflozin at 0.5 mg/kg/day in rats was 7 times the clinical exposure at maximal therapeutic dose (10 mg). In conclusion, dapagliflozin does not act as promoter or progressor of bladder cancer in a validated bladder cancer model in rats.

Spontaneous Findings in the Eyes of Cynomolgus Monkeys ( Macaca fascicularis) of Mauritian Origin.

Spontaneous findings noted in the eyes of Mauritian cynomolgus monkeys are described and descriptions are supplemented with illustrations. Findings observed after extensive histopathologic examinations (20 to 44 sections per eye) from 20 control, 17 treatment-naive stock monkeys, and 2 findings noted in drug-treated monkeys that were considered to be spontaneous are included. Also included are findings from 361 control monkeys of routine toxicity studies performed at our laboratories, for most of which a standard histopathological examination of 1 section per eye was conducted. Common observations in monkeys examined extensively and in historical controls were limited to lymphocytic or mononuclear cell infiltrations of the uvea and/or conjunctiva/sclera and, less commonly observed, melanocytoma of the ciliary body or iris. Findings noted only in monkeys examined extensively consisted of inflammation of the conjunctiva, ora serrata cysts, glial nodules, focal degeneration of the retina, cystoid degeneration of the central retina, ballooning degeneration of the ciliary epithelium, cyst of the ciliary body, and decreased pigmentation of the retinal pigment epithelium. Changes recorded only in historical controls included retinal atrophy and nuclear displacement in the retina. Lesions are discussed and compared with pertinent literature.

Evaluation of Uracil, Sodium Ascorbate, and Rosiglitazone as Promoters of Urinary Bladder Transitional Cell Carcinomas in Male Sprague-Dawley Rats.

The purpose of this study was to establish a 2-stage model of urinary bladder carcinogenesis in male Sprague-Dawley rats to identify tumor promoters. In phase 1 of the study, rats ( n = 170) were administered 100 mg/kg of the tumor initiator, N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN), twice weekly by oral gavage (po) for a period of 6 weeks. Phase 2 consisted of dividing rats into 4 groups ( n = 40 per group) and administering one of the following for 26 weeks to identify putative tumor promoters: (1) vehicle po, (2) 25 mg/kg/day rosiglitazone po, (3) 5% dietary sodium l-ascorbate, and (4) 3% dietary uracil. Rats were necropsied after 7.5 months, and urinary bladders were evaluated by histopathology. BBN/vehicle treatments induced the development of urothelial hyperplasia (83%) and papillomas (15%) but no transitional cell carcinomas (TCCs). Rosiglitazone increased the incidence and severity of papillomas (93%) and resulted in TCC in 10% of treated rats. Uracil was the most effective tumor promoter in our study and increased the incidence of papillomas (90%) and TCC (74%). Sodium ascorbate decreased the incidence of urothelial hyperplasia (63%) and did not increase the incidence of urothelial papillomas or TCC. These data confirm the capacity of our 2-stage model to identify urinary bladder tumor promoters.

Long-term treatment with eldecalcitol (1α, 25-dihydroxy-2ß- (3-hydroxypropyloxy) vitamin D3) suppresses bone turnover and leads to prevention of bone loss and bone fragility in ovariectomized rats.

The purpose of this study is to estimate the efficacy of eldecalcitol (1α, 25-Dihydroxy-2ß- (3-hydroxypropyloxy) vitamin D3; ELD) on bone metabolism after long-term administration. Six-month-old Wistar-Imamichi rats were ovariectomized (OVX) and administered ELD orally at doses of 7.5, 15, or 30 ng/kg daily. Bone mineral density (BMD), urinary excretion of deoxypyridinoline (DPD), a bone resorption marker, and serum total alkaline phosphatase (ALP), a surrogate marker of bone formation, were assessed after 3, 6, and 12 months of treatment. After 12 months of treatment, the biomechanical strength of the L4 lumbar vertebra and femoral shaft was measured, and bone histomorphometry was performed on the L3 lumbar vertebra and the tibia diaphysis. ELD prevented OVX-induced decreases in BMD of the lumbar vertebrae and femur throughout the treatment period. ELD significantly suppressed OVX-induced increases in urinary DPD excretion throughout the treatment period with minimal effects on ALP. OVX resulted in significant decreases in ultimate load and stiffness of the L4 lumbar vertebra and femoral shaft, and ELD significantly prevented the reduction in these biomechanical parameters. Bone histomorphometry at the L3 lumbar vertebra revealed that OVX induced increases in bone resorption parameters (osteoclast surface and osteoclast number) and bone formation parameters (osteoblast surface, osteoid surface, and bone formation rate), and ELD suppressed these parameters after 12 months treatment. Activation frequency, which was elevated in the OVX/vehicle group, was significantly suppressed to baseline levels in ELD-treated groups, indicating that ELD maintained bone turnover at a normal level. ELD also prevented OVX-induced deterioration of microstructure in trabecular and cortical bone. These results indicated that long-term treatment of OVX rats with ELD suppressed bone turnover, and prevented OVX-induced bone loss, deterioration of bone microstructure, and reduction in bone biomechanical strength.

Rat-specific decreases in platelet count caused by a humanized monoclonal antibody against sclerostin.

LY2541546 is a humanized monoclonal antibody (IgG(4)) that has been optimized for neutralizing activity against sclerostin. In 5-week and 6-month nonclinical safety studies in rats, LY2541546 caused dose-dependent reversible decreases in platelet counts accompanied by accelerated platelet production, increased megakaryocytes, and altered megakaryocyte morphology. These treatment-related effects resulted in altered primary hemostasis as manifested by prolonged bleeding after phlebotomy or incidental toenail break. In some cases, the defects in hemostasis were sufficient to result in death of the affected rats. There was no evidence in rats of general bone marrow suppression or processes (e.g., disseminated intravascular coagulopathy) that may result in thrombocytopenia. Cynomolgus monkeys given LY2541546 for 5 weeks or 9 months had no changes in platelet count or megakaryocytes. In vitro cross-reactivity studies in rats, cynomolgus monkeys, and humans revealed LY2541546-bound rat but not cynomolgus monkey or human platelets and megakaryocytes. These data taken together demonstrated that the platelet and megakaryocyte effects in rats had a species-specific pathogenesis which likely involved LY2541546 binding of a rat-specific antigen on the surface of platelets and megakaryocytes resulting in the increased clearance of platelets and megakaryocyte hyperplasia. The species-specific nature of these reversible toxicological findings combined with the ease of clinical monitoring using standard hematology enabled the safe initiation of clinical studies in human volunteers.

Intervention to reduce parental bypass of community pediatric primary health facilities in asmara, eritrea.

OBJECTIVE: To reduce direct parental referral of low acuity ill pediatric patients to the outpatient facilities of a nation's only pediatric referral hospital. PATIENTS AND METHODS: Longitudinal monitoring of outpatient visits at Orotta Children's Hospital (OCH) and primary health facilities (PHFs) following implementation of an intervention designed in response to information provided by parents and health-care providers. Parental surveys were undertaken before and after exposure to the intervention to assess effects on knowledge, attitudes, and behavioral intentions. RESULTS: We analyzed 5,639 visits between baseline and follow-up, documenting a decline in parental referral among OCH outpatients from 95% to approximately 80%. Educational intervention increased the proportion of parents intending to use PHF for future outpatient care from 28% to 82%. Staff of the PHFs responded enthusiastically to this intervention program and requested further activities. CONCLUSIONS: Self-referral to tertiary care hospital was reduced following a modest program of parental education designed and implemented by residents in training.

Profile of patients with diabetes in Eritrea: results of first phase registry analyses.

A cross-sectional descriptive study was done on patients recently entered into the National Diabetes Registry in Eritrea where the prevalence was estimated to be 2.2% based on patient information in 2004. Of the 627 patients with diabetes, two thirds were type 2. Although type 1 had poorer control (42.9%) than type 2 (29.9%), some of the risk factors such as cholesterol (43.4 vs. 28.2%), triglyceride (23.4 vs. 12.8%), hypertension (55.2 vs. 12.7%) as well as BMI and waist/hip ratio were higher in type 2 than type 1. More than one-third (41.2%) of patients with type 2 compared to type 1 (19.5%) had complications, the commonest being retinopathy (33%) followed by foot ulcers (14%) and neuropathy (4%). Many of the diabetic patients demonstrated the presence of the metabolic syndrome components such as hypertension, obesity and dyslipidemia. The authors conclude that diabetes registry is invaluable in providing evidence-based prevention and control of the disease.

Carbon storage of different soil-size fractions in Florida silvopastoral systems.

Compared with open (treeless) pasture systems, silvopastoral agroforestry systems that integrate trees into pasture production systems are likely to enhance soil carbon (C) sequestration in deeper soil layers. To test this hypothesis, total soil C contents at six soil depths (0-5, 5-15, 15-30, 30-50, 50-75, and 75-125 cm) were determined in silvopastoral systems with slash pine (Pinus elliottii) + bahiagrass (Paspalum notatum) and an adjacent open pasture (OP) with bahiagrass at four sites, representing Spodosols and Ultisols, in Florida. Soil samples from each layer were fractionated into three classes (250-2000, 53-250, and <53 microm), and the C contents in each were determined. Averaged across four sites and all depths, the total soil organic carbon (SOC) content was higher by 33% in silvopastures near trees (SP-T) and by 28% in the alleys between tree rows (SP-A) than in adjacent open pastures. It was higher by 39% in SP-A and 20% in SP-T than in open pastures in the largest fraction size (250-2000 microm) and by 12.3 and 18.8%, respectively, in the intermediate size fraction (53-250 microm). The highest SOC increase (up to 45 kg m(-2)) in whole soil of silvopasture compared with OP was at the 75- to 125-cm depth at the Spodosol sites. The results support the hypothesis that, compared with open pastures, silvopastures contain more C in deeper soil layers under similar ecological settings, possibly as a consequence of a major input to soil organic matter from decomposition of dead tree-roots.